International Society For Pharmacoepidemiology
- Assets
- $4.2m
- Revenue
- $827.5k
- Investments
- $0.0
- Employees
- 0
- Location
- Washington, DC
- Founding
- 07/1994
- Data as of
- 06/2022
- EIN
- 41-1688677
Organization Overview
International Society For Pharmacoepidemiology, operating under the name Ispe, is located in Washington, DC. The organization was established in 1994. According to its NTEE Classification (G90) the organization is classified as: Medical Disciplines, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Ispe is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 06/2022, Ispe generated $827.5k in total revenue. This represents a relatively dramatic decline in revenue. Over the past 7 years, the organization has seen revenues fall by an average of (11.2%) each year. All expenses for the organization totaled $892.0k during the year ending 06/2022. As we would expect to see with falling revenues, expenses have declined by (7.9%) per year over the past 7 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
SEE SCHEDULE O
Describe the Organization's Program Activity:
Part 3 - Line 4a
DEVELOPMENT AND MANAGEMENT OF SCIENTIFIC FORUMS: 1) CONVENE AN ANNUAL SCIENTIFIC FORUM (INTERNATIONAL CONFERENCE ON PHARMACOEPIDEMIOLOGY & THERAPEUTIC RISK MANAGEMENT - ICPE) WHERE MEMBERS OF THE DISCIPLINE MEET TO NETWORK, PRESENT RESULTS OF METHODOLOGICAL INVESTIGATIONS AND STUDIES IN PROGRESS, DISCUSS PUBLIC HEALTH POLICY ISSUES CONCERNING PHARMACOEPIDEMIOLOGY, THERAPEUTIC RISK MANAGEMENT, AND OTHER RELATED FIELDS. 2) CONVENE REGULAR REGIONAL AND LOCAL MEETINGS ON SCIENTIFIC AND PUBLIC POLICY ISSUES, WHICH CURRENTLY INCLUDES A MID-YEAR CONFERENCE IN CONJUNCTION WITH MEETINGS OF THE BOARD OF DIRECTORS AND SCIENTIFIC PROGRAM COMMITTEE; AND AN ANNUAL ASIAN CONFERENCE (ACPE) PARTNERED WITH LOCAL SCIENTIFIC AND PROFESSIONAL SOCIETIES.
PUBLICATIONS: 1) THE SOCIETY PROVIDES A MEMBERS-ONLY SUBSCRIPTION TO PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, A LEADING SCIENTIFIC JOURNAL PUBLISHING DEFINITIVE, PEER-REVIEWED PAPERS ON THE SCIENCE AND PRACTICE OF PHARMACOEPIDEMIOLOGY; AND 2) A MANUSCRIPT INITIATIVE, WHICH FUNDS THE DEVELOPMENT OF RESOURCE DOCUMENTS FOCUSED ON PHARMACOEPIDEMIOLOGY, PHARMACOVIGILANCE, DRUG UTILIZATION RESEARCH, OUTCOMES RESEARCH, COMPARATIVE EFFECTIVENESS RESEARCH, AND THERAPEUTIC RISK MANAGEMENT.
THE SOCIETYS COMMUNICATIONS PROGRAM DELIVERS: 1) A WEBSITE WITH SIGNIFICANT RESOURCES ON THE EXPANDING SCIENCE AND PRACTICE OF PHARMACOEPIDEMIOLOGY, AND PRESENTS ISPES GOALS AND OBJECTIVES TO CURRENT/PROSPECTIVE MEMBERS, AND THE GENERAL PUBLIC; AND 2) REGULAR EMAIL UPDATES TO MEMBERS ON DEVELOPMENTS IN PHARMACOEPIDEMIOLOGY, OR ABOUT ISPE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Mary Ritchey Director | Trustee | 1 | $0 |
1 Ursula Kirchmayer Director | Trustee | 1 | $0 |
Stanley Edlavitch Executive Director Emeritus | Trustee | 1 | $0 |
Fredrik Nyberg Director | Trustee | 1 | $0 |
Montserrat Soriano Gabarro Director | Trustee | 1 | $0 |
Yoshiaki Uyama Director | Trustee | 1 | $0 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Pai Management Corp Management | 6/29/22 | $543,195 |
Bella Opr As Venue Rentalfood | 6/29/22 | $324,538 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $0 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
| Total Program Service Revenue | $787,810 |
| Investment income | $32,417 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $7,295 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $827,522 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $5,406 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $495,390 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $12,439 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $69,629 |
| Advertising and promotion | $713 |
| Office expenses | $16,398 |
| Information technology | $126,570 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $22,648 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $3,694 |
| All other expenses | $0 |
| Total functional expenses | $891,957 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $409,306 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $124,750 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $947,565 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $2,742,691 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $4,224,312 |
| Accounts payable and accrued expenses | $43,475 |
| Grants payable | $0 |
| Deferred revenue | $679,647 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $723,122 |
| Net assets without donor restrictions | $3,501,190 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,224,312 |